World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
115119
World Ranking
4100
National Ranking
401

Peter Sleight publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter Sleight sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 493 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter Sleight D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Sleight sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter Sleight was affiliated with the John Radcliffe Hospital in the United Kingdom. Their research primarily focused on the medical field, with a particular emphasis on cardiology and cardiovascular medicine. Their work spanned related subfields including endocrinology, diabetes and metabolism, surgery, emergency medicine, and cancer research.

Their published papers covered key topics in cardiovascular health and hypertension. Recent notable publications included:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure, 2021, The Lancet
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death, 2021, The Lancet
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis, 2021, The Lancet Oncology
  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis, 2022, The Lancet Diabetes & Endocrinology

Their research addressed multiple main topics including blood pressure and hypertension studies, heart rate variability and autonomic control, hormonal regulation and hypertension, cardiac health and mental health, lipoproteins and cardiovascular health, diabetes-related cardiovascular risks, and HIV-related health complications and treatments.

Frequent co-authors included colleagues such as Colin Baigent, Amanda Adler, Rory Collins, Barry R. Davis, and Louise Bowman. The consistent collaboration with these researchers reflected a focused research network centered on cardiovascular and metabolic health studies.

Peter Sleight's work was frequently published in respected medical journals such as The Lancet, Ophthalmology, The Lancet Oncology, The Lancet Diabetes & Endocrinology, and the European Heart Journal. This distribution of publication venues indicated engagement with a wide clinical and research audience within cardiovascular and related systemic medicine fields.

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

    R Altman;L Carreras;R Diaz;E Figueroa

  • Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

    Koon K. Teo;Janice Pogue;Leanne Dyal;Ingrid Copland

  • Beta blockade during and after myocardial infarction: an overview of the randomized trials

    Salirn Yusuf;Richard Peto;John Lewis;Rory Collins

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redán

  • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials

    J Fulcher;R O'Connell;M Voysey

  • Effect of age and high blood pressure on baroreflex sensitivity in man.

    Brian Gribbin;Thomas G. Pickering;Peter Sleight;Richard Peto

  • Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

    Rory Collins;Jane Armitage;Sarah Parish;Peter Sleight

  • Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

    Eva Lonn;Jackie Bosch;Salim Yusuf;Patrick Sheridan

  • Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

    S Yusuf;K Teo;C Anderson

  • Controlled trial of physical training in chronic heart failure: Exercise performance, hemodynamics, ventilation, and autonomic function

    A J Coats;S Adamopoulos;A Radaelli;A McCance

  • Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

    Henry R. Black;William J. Elliott;Gregory Grandits;Patricia Grambsch

  • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

    J O'Brien;H Duncan;G Kirsh;V Allen

  • Changes in autonomic regulation induced by physical training in mild hypertension.

    M Pagani;V Somers;R Furlan;S Dell'Orto

  • HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

    R. Haynes;L. Jiang;J. C. Hopewell;J Li

  • 2013 ESH/ESC Practice guidelines for the management of arterial hypertension

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • Cardiovascular, cerebrovascular, and respiratory changes induced by different types of music in musicians and non-musicians: the importance of silence

    Luciano Bernardi;Cesare Porta;Peter Sleight

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Rory Collins
Rory Collins University of Oxford
Richard Peto
Richard Peto University of Oxford
Koon K. Teo
Koon K. Teo McMaster University
Andrew J.S. Coats
Andrew J.S. Coats The Heart Research Institute
Craig S. Anderson
Craig S. Anderson George Institute for Global Health
John S. Floras
John S. Floras University Health Network
Giuseppe Mancia
Giuseppe Mancia University of Milano-Bicocca
Roland E. Schmieder
Roland E. Schmieder University of Erlangen-Nuremberg
Alberto Zanchetti
Alberto Zanchetti University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA means exploring a spectrum of online degrees and accelerated learning pathways. Many healthcare professionals who want to advance quickly consider the 1 year dnp program online as an efficient route to earn a Doctor of Nursing Practice in a fraction of the standard time. These programs are designed for those seeking leadership or advanced clinical roles.

There are also dnp programs tailored for flexibility and accessibility, providing options for nurses at various stages in their careers. For those beginning their journey, lpn programs offer streamlined entry into the nursing profession, often with the added benefit of remote learning and speedy completion.

If you already hold an advanced degree, the fastest post master's pmhnp programs provide direct pathways into specialized practice in mental health. Overall, these online opportunities allow for career growth while balancing work and personal commitments—making them ideal for both new and experienced healthcare professionals.

Best Scientists Citing Peter Sleight

Recently Published Articles